You just read:

Lexicon Pharmaceuticals Reports Positive Pooled Continuous Glucose Monitoring Data From Pivotal Phase 3 inTandem1 And inTandem2 Studies Of Sotagliflozin

News provided by

Lexicon Pharmaceuticals, Inc.

Sep 08, 2017, 07:00 ET